Hypovitaminosis D promotes MED12-associated genomic instability in uterine fibroids
维生素 D 缺乏促进子宫肌瘤中 MED12 相关基因组不稳定性
基本信息
- 批准号:10330261
- 负责人:
- 金额:$ 8.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-02-15 至 2023-01-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAddressAffectAfricaAfrica South of the SaharaAfricanAfrican AmericanAnimal ModelApoptosisBRCA1 geneBenignBiochemicalCaucasiansCell ProliferationCell modelChicagoCholecalciferolChromosomal LossChromosomal RearrangementCollaborationsComplementConsentDNA DamageDNA Double Strand BreakDNA Repair PathwayDevelopmentDown-RegulationEpigallocatechin GallateEthnic OriginEtiologyExperimental DesignsFemale Genital NeoplasmsFertilityFibroid TumorFibrous capsule of kidneyFreezingFundingFutureGene ExpressionGene Expression ProfilingGenesGeneticGenetic TranscriptionGenomic InstabilityGhanaGoalsHealthHealth Care CostsHospitalsHumanHysterectomyImpairmentIn VitroIncidenceInflammationInfrastructureInterventionKenyaLeiomyomaLesionLinkMediator of activation proteinMedicalMedical centerModelingMolecularMorbidity - disease rateNational Institute of Child Health and Human DevelopmentNatural ProductsOperative Surgical ProceduresOralPathogenesisPathway interactionsPatientsPerioperativePremenopauseProceduresProcessProtocols documentationPublishingRaceReceptor SignalingRelative RisksReportingResearchResearch PriorityRiskSamplingSavingsSerumShipsSignal PathwaySignal TransductionSomatic MutationSupplementationTherapeuticTherapeutic EmbolizationTherapeutic InterventionTimeTissuesTrainingTreatment EfficacyTumor BurdenUniversitiesUterine FibroidsUterine myomectomyVitamin DVitamin D DeficiencyVitamin D3 ReceptorVitamin DeficiencyWomanWomen&aposs Healthbaseblack womencost effectivecost estimatedesigndriving forcefertility preservationgene repairhealth disparityhealthy pregnancyhuman modelinnovationmortalitymouse modelmutantmyometriumneoplasticnovelparent grantpre-clinicalracial disparityresponsestem cellstranscriptome sequencingtranscriptomicstumortumor growthtumor progression
项目摘要
Abstract of Funded Parent Grant
UFs (leiomyomas) are the most important benign neoplastic threat to women’s health worldwide,
with annual health care costs estimated in the hundreds of billions of dollars. UF caused-
morbidities negatively impact women of all ethnicities, but disproportionately affect African
American (AA) women, who have a threefold higher incidence rate and relative risk of UFs than
Caucasian (CC) women. While the basis for this risk disparity is not fully understood, recent
studies implicate hypovitaminosis D as a major contributor. Thus, AA women have a tenfold
increased risk of vitamin D deficiency compared to CC women, and as we first reported, UF risk
is inversely correlated with 25-hydroxy vitamin D serum levels. Nonetheless, it is not clear whether
and how the processes that drive UF formation and racial risk disparity are genetically or
biochemically linked. Herein, we suggest a mechanistic basis to couple UF etiology and relative
risk association through a functional interplay between vitamin D3 and an altered DNA damage
response network in MED12-mutant UFs, and further offer proof of concept for therapeutic
intervention in this genetic setting. Recently, we and others identified somatic mutations in the
transcriptional Mediator subunit MED12 as the dominant drivers of UFs, accounting for ~70% of
tumors. Notably, MED12-mutant UFs are characterized by significant chromosomal loss and
rearrangement, suggesting genomic instability as a driving force in tumor progression. Herein, we
clarify the molecular basis for mutant MED12-driven genomic instability, and further identify
vitamin D3 receptor signaling as a likely suppressor of this process. We show that MED12-mutant
UF stem cells (SCs) accumulate high levels of unrepaired DNA double-strand breaks (DSBs)
through downregulation of key DNA damage response (DDR) and repair genes, including RAD50,
RAD51 and BRCA1. Notably, we find the vitamin D3/receptor axis to be a variable modulator of
MED12-regulated DDR gene expression. Thus, we show that reduced vitamin D3/receptor
signaling suppresses, while elevated signaling
activates, DDR genes downregulated in MED12-mutant UF SCs. Based on these findings, we
hypothesize that hypovitaminosis D exacerbates DNA damage accumulation and genomic
instability arising in MED12-mutant UFs, leading to enhanced tumor progression and burden.
Accordingly, we propose that vitamin D3, through reparation of an impaired DDR, will provide
therapeutic benefit in MED12-mutant tumors. To confirm and extend these hypotheses, we
propose the following aims, which directly address and mechanistically connect three
overarching issues in the field: the molecular pathogenesis of UFs, the racial disparity in UF
risk, and the development of novel tolerable fertility-saving and cost-effective oral therapies for
UFs.
资助父母补助金摘要
UFs(平滑肌瘤)是全球女性健康最重要的良性肿瘤威胁,
每年的医疗费用估计达数千亿美元。UF引起的-
发病率对所有族裔的妇女都有负面影响,但对非洲妇女的影响更大。
美国(AA)妇女,谁有三倍高的发病率和相对风险的UF比
高加索(CC)女性。虽然这种风险差异的基础尚未完全理解,但最近
研究表明维生素D缺乏症是主要原因。因此,AA女性有十倍的
与CC女性相比,维生素D缺乏的风险增加,正如我们首次报道的那样,UF风险
与25-羟基维生素D血清水平呈负相关。然而,尚不清楚是否
以及驱动UF形成和种族风险差异的过程是如何遗传或
生物化学联系。在此,我们提出了一个机制的基础,夫妇UF病因和相关的
通过维生素D3和改变的DNA损伤之间的功能性相互作用的风险关联
MED12突变型UF中的反应网络,并进一步为治疗性UFs提供概念证明。
在这种遗传背景下的干预。最近,我们和其他人发现了体细胞突变,
转录介导子亚基MED12是UF的主要驱动因子,约占UF的70%。
肿瘤的值得注意的是,MED12突变型UF的特征在于显著的染色体丢失,
这表明基因组不稳定性是肿瘤进展的驱动力。在此我们
阐明突变MED12驱动的基因组不稳定性的分子基础,并进一步确定
维生素D3受体信号传导作为这一过程的可能抑制剂。我们发现MED12突变体
UF干细胞(SC)积累高水平的未修复的DNA双链断裂(DSB)
通过下调关键的DNA损伤反应(DDR)和修复基因,包括RAD 50,
RAD51和BRCA1。值得注意的是,我们发现维生素D3/受体轴是一个可变的调节剂,
MED12调节DDR基因表达。因此,我们表明,减少维生素D3/受体,
信号抑制,而信号升高
激活,DDR基因在MED12突变UF SC中下调。基于这些发现,我们
假设维生素D缺乏症加剧了DNA损伤积累和基因组
MED12突变型UF中出现的不稳定性,导致肿瘤进展和负荷增强。
因此,我们建议,维生素D3,通过修复受损的DDR,将提供
MED12突变型肿瘤的治疗益处。为了证实和扩展这些假设,我们
我提出以下目标,直接解决和机械连接三个
该领域的首要问题:UF的分子发病机制,UF的种族差异
风险,并开发新的可耐受的生育率节省和成本效益的口服疗法,
UFs。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ayman Al-Hendy其他文献
Ayman Al-Hendy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ayman Al-Hendy', 18)}}的其他基金
Pathological reprogramming of the m6A epitranscriptome in uterine fibroids
子宫肌瘤中 m6A 表观转录组的病理重编程
- 批准号:
10641809 - 财政年份:2021
- 资助金额:
$ 8.82万 - 项目类别:
Pathological reprogramming of the m6A epitranscriptome in uterine fibroids
子宫肌瘤中 m6A 表观转录组的病理重编程
- 批准号:
10300115 - 财政年份:2021
- 资助金额:
$ 8.82万 - 项目类别:
Gene X Environment Interactions in the Pathogenesis of Uterine Fibroids
子宫肌瘤发病机制中 X 基因环境相互作用
- 批准号:
10286273 - 财政年份:2020
- 资助金额:
$ 8.82万 - 项目类别:
Gene X Environment Interactions in the Pathogenesis of Uterine Fibroids
子宫肌瘤发病机制中 X 基因环境相互作用
- 批准号:
10300580 - 财政年份:2020
- 资助金额:
$ 8.82万 - 项目类别:
Investigating the effectiveness of COVID-19 testing choices, community engagement, and culturally-embedded mHealth literacy delivery in a medically-underserved, community-based sample
在医疗服务不足、基于社区的样本中调查 COVID-19 检测选择、社区参与和嵌入文化的移动医疗素养传播的有效性
- 批准号:
10570318 - 财政年份:2020
- 资助金额:
$ 8.82万 - 项目类别:
Community-Engaged Covid-19 Interventions to Protect and Monitor Children
社区参与 Covid-19 干预措施以保护和监测儿童
- 批准号:
10403857 - 财政年份:2020
- 资助金额:
$ 8.82万 - 项目类别:
Investigating the effectiveness of COVID-19 testing choices, community engagement, and culturally-embedded mHealth literacy delivery in a medically-underserved, community-based sample
在医疗服务不足、基于社区的样本中调查 COVID-19 检测选择、社区参与和嵌入文化的移动医疗素养传播的有效性
- 批准号:
10258548 - 财政年份:2020
- 资助金额:
$ 8.82万 - 项目类别:
3/4, University of Illinois at Chicago Clinical Site- Reproductive Medicine Collaborative Consortium: A randomized placebo-controlled trial of EGCG to improve fertility in women with uterine fibroids
3/4,伊利诺伊大学芝加哥分校临床中心 - 生殖医学协作联盟:一项 EGCG 改善子宫肌瘤女性生育能力的随机安慰剂对照试验
- 批准号:
10477436 - 财政年份:2019
- 资助金额:
$ 8.82万 - 项目类别:
3/4, University of Illinois at Chicago Clinical Site- Reproductive Medicine Collaborative Consortium: A randomized placebo-controlled trial of EGCG to improve fertility in women with uterine fibroids
3/4,伊利诺伊大学芝加哥分校临床中心 - 生殖医学协作联盟:一项 EGCG 改善子宫肌瘤女性生育能力的随机安慰剂对照试验
- 批准号:
10025600 - 财政年份:2019
- 资助金额:
$ 8.82万 - 项目类别:
3/4, University of Illinois at Chicago Clinical Site- Reproductive Medicine Collaborative Consortium: A randomized placebo-controlled trial of EGCG to improve fertility in women with uterine fibroids
3/4,伊利诺伊大学芝加哥分校临床中心 - 生殖医学协作联盟:一项 EGCG 改善子宫肌瘤女性生育能力的随机安慰剂对照试验
- 批准号:
10878669 - 财政年份:2019
- 资助金额:
$ 8.82万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 8.82万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 8.82万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 8.82万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 8.82万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 8.82万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 8.82万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 8.82万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 8.82万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 8.82万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 8.82万 - 项目类别:
Research Grant